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Background and objective: Conventional methods to establish pleural infection are time-
consuming and sometimes inadequate. Biomarkers may aid in making rapid diagnosis of infec-
tion. In an observational study we evaluated and compared the diagnostic value of pleural fluid
levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), C-reactive protein
and procalcitonin in intensive care patients with pleural effusions.
Methods: Thirty-six patients with de novo pleural effusions were included and 20 patients with
pleural effusions after cardiothoracic surgery and 20 patients with pleural effusions after
esophagus surgery acted as controls. Levels of sTREM-1, C-reactive protein and procalcitonin
were measured in pleural effusions.ering receptor expressed on myeloid cells-1; CRP, C-reactive protein; PCT, procalcitonin.
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sTREM-1 levels in pleural effusions 311Results: Levels of sTREM-1 were highest in empyemas, followed by infectious exudates. Levels
of sTREM-1 were low in transudates and non-infectious exudates. C-reactive protein levels
were highest in exudates and empyemas, while procalcitonin levels were highest in exudates.
Pleural fluid with positive culture results contained higher sTREM-1 and C-reactive protein
levels as compared to samples with negative culture results. A cut-off level of 50 pg/
ml sTREM-1 yielded a sensitivity of 93% and a specificity of 86%, while these were 87% and
67% respectively for a cut-off value of 7.5 mg/ml C-reactive protein, and 60% and 64% respec-
tively for a cut-off value of 0.15 ng/ml procalcitonin.
Conclusion: sTREM-1 is superior to C-reactive protein and procalcitonin in detecting infection.
ª 2009 Published by Elsevier Ltd.Introduction
Pleural effusions are an important complication of several
diseases and may cause additional morbidity, also in
patients admitted to the intensive care.1 The clinical
presentation of a patient is important in establishing the
cause of an effusion.1 However, if the cause of pleural
effusion is uncertain or unknown, further diagnostical
procedures are warranted. Diagnosing infection is impor-
tant as delayed antibiotic therapy may result in addi-
tional morbidity.2 Current guidelines recommend routine
microbiological studies to aid in the decision of antimi-
crobial treatment and the need for drainage.1 However,
Gram stains are not always conclusive and awaiting
culture results may result in delayed diagnosis and
therapy resulting in complicated parapneumonic effusions
or pleural empyema.2 By contrast, treating all patients
with antimicrobial agents before culture results are
available will lead to overuse of antimicrobial agents with
the associated risk of antibiotic resistance and higher
costs.3
Accurate markers to establish the presence of infection
are needed. Several proteins that are elevated in sera of
patients with systemic infection have been suggested as
markers of infection in pleural effusions.4e10 Recently,
soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) has been proposed by us and others as
a specific marker of infection in patients with sepsis,
pneumonia or bacterial meningitis.11e14 Experimental
studies have shown that TREM-1 is up-regulated on
myeloid cells if these cells make contact with bacterial
components.15 Simultaneously, a soluble form of TREM-1 is
released.15 Studies in patients with pneumonia and
bacterial meningitis have shown that if this protein is
measured locally, i.e. on the site of infection, its occur-
rence is strongly correlated with active infection.12e14
Indeed, two recent studies have shown that levels of
sTREM-1 are elevated in infectious pleural effusions.4,5 In
parallel, other locally detectable markers of inflammation
were suggested to be useful in the diagnosis of pleural
infection. C-reactive protein (CRP) levels were shown to
be higher in patients with infectious pleural effusions as
compared to effusions in the context of tuberculosis or
malignancy.7 The differentiating capacity of CRP for
infection was demonstrated to be superior to that of the
inflammatory cytokines interleukin-6 and tumor necrosis
factor-a.7 Furthermore, pleural effusion levels of pro-
calcitonin (PCT) were shown to be higher in patients withtuberculosis as compared to patients with effusions asso-
ciated to malignancy.6
As previous studies have shown that locally measured
sTREM-1 levels are highly correlated with the presence of
infection, we evaluated the diagnostic value of pleural
fluid levels of sTREM-1 as a biological marker of infection
in intensive care patients with pleural effusions. More-
over, the diagnostic value of pleural fluid levels of sTREM-
1, CRP and PCT has been studied separately only.
Therefore, in the present study we evaluated and
compared the diagnostic capacity of each of these
markers.
Methods
Patients
Critically ill patients with a de novo presentation of
a pleural effusion during the course of their stay on the
intensive care were eligible for the study. Only patients in
whom pleural effusions were drained were included in the
study. Indications for drainage were diagnostical purposes
in case an exudate was suspected (e.g., in case of sus-
pected infection) or for respiratory failure considered to be
the consequence of the pleural effusion. Patients with
a pleural effusion within 24 h after cardiothoracic or
esophagus surgery served as control patients. In view of the
observational nature of the study the institutional ethical
committee of the Academic Medical Center mandated
neither retrospective patient consent nor formal assent
from relatives to be required.
Study protocol
Drainage was performed either by insertion of a sterile
Pneumo-cath (Intra special catheters GmbH, Rehlingen-
Siersburg, Germany) or a sterile thorax drain (Tyco
Healthcare, Tullamore, Ireland). In control patients who
had a thorax drain after cardiothoracic or esophagus
surgery, pleural fluid was collected from the indwelling
thorax drain by aspiration with a sterile needle. Immedi-
ately after fluid had been obtained, samples were sent to
the bacteriological department and the clinical hospital
laboratory for routine analyses. These consisted of culture
and measurement of levels of lactate dehydrogenase, total
protein and cholesterol, and leukocyte count with differ-
entiation. For study purposes fluid was centrifuged at
312 R.M. Determann et al.1500 g for 10 min at 4 C, and supernatant was collected
and stored at 80 C until measurement of levels of sTREM-
1, CRP and PCT.
Classification of pleural effusions
All pleural effusions were classified into transudates or
exudates according to the criteria of Light or as empyema
based on the macroscopic presence of pus.1 In case an
exudates was positive on bacteriological culture than this
effusion was classified as infectious. Classification of effu-
sions was performed before analysis of biological markers.
Measurements
Levels of sTREM-1 were measured with an enzyme-linked
immunosorbent assay as described previously.14 The
sensitivity of this assay is 10 pg/ml and results can be
obtained within 4 h. Levels of CRP were measured with an
automated immunoturbid assay. The sensitivity of this
assay is 1 mg/ml and results are obtained within 1 h. PCT
was measured with a sensitive luminescence immunoassay
(Brahms, Berlin, Germany). This assay takes 2 h and the
sensitivity is 0.05 ng/ml. All measurements were made in
duplicate.
Statistical analysis
Data are presented as medians [range] or means ( standard
deviation) as appropriate. Baseline characteristics were
evaluated with analysis of variance or the Kruskal Wallis testTable 1 Baseline characteristics of patients with de novo pleu
Transudate
(nZ 13)
Exudate
(nZ 38)
Age (years) 54 10 66 16
Male sex (n, %) 5 (38%) 25 (66%)
Admission diagnosis
Pancreatitis 1
Bowel perforation 1
Trauma 2
Aspiration pneumonia 3
Community-acquired
pneumonia
Resuscitation after
ventricular fibrillation
4
Heart failure 9
Cardiac surgery 20
Esophagus cardia resection 11
Blood leukocyte
count (x 109/l)
11.6 4.0 12.5 4.2
PE leukocyte
count (x 109/l)
0.5 [0e1.1] 3.6 [0e10.9
PE LDH (IU/l) 204 [103e891] 995 [243e3
PE cholesterol (mmol/l) Not detectable 1.6 0.7
PE total protein (g/l) Not detectable 28.5 18.9
PE glucose (mmol/l) 7.5 1.3 6.4 2.3
PE pH 7.4 0.04 7.4 0.08
PE pleural effusion; LDH lactate dehydrogenase; *P< 0.05 vs. all othas appropriate. Differences in levels of sTREM-1, CRP or PCT
between groups were analyzed with post-hoc analysis
(Dunn’s multiple comparison test). Categorical data were
analyzed with the c2- or Fisher’s exact test. Relations
between sTREM-1, CRP and PCT levels and clinical or bio-
logical features were assessed with use of the Spearman’s
correlation test. To estimate the ability to discriminate
between infectious and non-infectious pleural effusions,
receiver operating characteristic (ROC) analysis was per-
formedand theareaunder the curve (AUC)was calculated. In
this analysis, a model with an AUC between 0.7 and 0.8 is
considered clinically useful. A model with an AUC between
0.8 and 0.9 has excellent diagnostic accuracy. If the AUC
approaches 1.0, the model approaches 100% sensitivity and
specificity. All analyses were done with SPSS, version 14.0
and GraphPad Prism, version 4.03. A P-value< 0.05 was
considered as statistically significant.
Results
Patients
Thirty-six consecutive patients with a de novo presentation
of pleural effusion were included from January until
December 2006; 20 patients with pleural effusions after
cardiothoracic surgery and 11 patients with pleural effu-
sions after esophagus surgery were included as control
patients. Patients with a de novo presentation were 55 13
years of age and 16 patients (44%) were male. The control
patients were of comparable age (57 13 years, PZ 0.52)
but more patients were male (79%, PZ 0.01). Of the 36ral effusion.
Infection
(nZ 5)
Complicated
infection (nZ 11)
P-value
63 6* 47 10 <0.01
4 (80%) 4 (36%) 0.11
1
2
2 11
12.2 6.4 16.0 8.9 0.60
] 2.0 [0.1e10.1]* e <0.01
933] 2197 [570e3787]* e <0.01
0.7 0.9 e
16.0 22.0 e <0.01
2.8 2.3* e <0.01
7.3 0.09* e 0.01
er groups on post-hoc analysis (Bonferroni).
Table 2 Isolated pathogens from pleural effusions and
associated illness.
Infection
(nZ 5)
Complicated
infection (nZ 11)
Coagulase negative
Staphylococci
1 2
Enterococcus faecium 2
Escherichia coli 2
Porphyromonas species 1
Serratia marescens 1
Staphylococcus aureus 2
Streptococcus pneumoniae 3
Streptococcus viridans 1
No micro-organism cultured 1
sTREM-1 levels in pleural effusions 313patients with a de novo presentation, 11 patients presented
with macroscopic pus in their effusion. The baseline char-
acteristics of the 25 patients presenting with a transudate
or exudate are presented in Table 1.
Of the patients presenting with new effusions, 11 effu-
sions were classified as empyema, 5 as infectious, 7 as
exudate and 13 as transudate. All of the effusions of control
patients were classified as exudates. In 15 patients (10 with
an empyema and 5 with an exudate) bacterial culture of
the pleural fluid was positive and in one patient with an
exudate no culture was performed. The isolated pathogens
are listed in Table 2. One patient with a macroscopic
empyema had a negative culture result. In this patient
empyema was drained after initiation of antibiotic
treatment.
Levels of sTREM-1, CRP, and PCT in pleural fluid
(Figure 1)
In empyemas, levels of sTREM-1 were significantly higher
(median, 922 [range, 0e2972] pg/ml) as compared to
exudates (0 [0e189] pg/ml) and transudates (0 [0e110]
pg/ml). Levels of sTREM-1 in infectious effusions (287
[131e395] pg/ml) were comparable to empyemas and
significantly higher compared to transudates and non-
infectious exudates.T
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Figure 1 Levels of soluble triggering receptor expressed on mye
patients with transudative pleural effusions, exudative pleural effLevels of CRP were higher in empyemas (86 [8e232] mg/
ml) and infectious effusions (42 [11e164] compared to
transudates (7 [1e83] and non-infectious exudates (2 [1e
118]. In post-hoc analysis all comparisons (empyema vs.
transudates and exudates, and infectious vs. transudates
and exudates) were statistically significant.
Levels of PCT were highest in infectious exudates (0.58
[0.05e30.00] ng/ml; P< 0.01). In contrast, PCT levels in
empyemas were low and not different from the levels in
transudates and non-infectious exudates.
Levels of sTREM-1, CRP and PCT in relation to the
presence of infection (Figure 2)
In patients with positive culture results, levels of sTREM-1
were significantly higher (302 [0e2972] pg/ml compared to
the levels in non-infected effusions 0 [0e1671] pg/ml;
P< 0.01). In one patient with pleural empyema but
a negative culture result, an sTREM-1 level of 1671 pg/ml
was found and the sTREM-1 level was 75 pg/ml in the
patients with an exudate of which no culture was per-
formed. This patient survived without antibiotic treatment.
In patients with positive culture results, CRP levels tended
to be higher as compared to patients with negative results
(78 [1e232] pg/ml versus 29 [1e160] pg/ml; PZ 0.11). In
contrast, no differences were found in PCT levels between
patients with positive or negative culture results.
Receiver operating characteristic curves (Figure 3)
As a next step, we constructed receiver operating charac-
teristic (ROC) curves to study the capacities of sTREM-1, CRP
and PCT to differentiate between infectious and non-
infectious pleural effusions. For the first analysis, all
patients and controls were included. The AUCs for sTREM-1
and CRP were 0.93 (95% CI 0.84e1.00; P< 0.01) and 0.81
(95% CI 0.69e0.93; P< 0.01) respectively. The AUC for PCT
was 0.62 (95% CI 0.45e0.80; PZ 0.17). For the identification
of infection, a cut-off value of 50 pg/ml for sTREM-1 resulted
in a sensitivity of 93% (95% CI 75e99) and a specificity of 86%
(95% CI 76e92). Sensitivity was 87% (95% CI 67e96) and
specificity 71% (95% CI 59e80) for a cut-off value of 10 mg/mlte
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Figure 2 Levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), C-reactive protein and procalcitonin in
patients with positive or negative culture results of pleural effusions.
314 R.M. Determann et al.for CRP and 60% (95% CI 39e78) and 64% (95% CI 52e74)
respectively for a cut-off value of 0.15 ng/ml for PCT.Discussion
Early diagnosis of infection in patients with pleural effu-
sions is essential for optimal treatment. While a definite
diagnosis of infection requires results of cultures of
obtained pleural fluid, use of biomarkers of infection may
result in earlier diagnosis and thus more appropriate
treatment. While recent studies have suggested sTREM-1,
CRP and PCT as biological markers for infection in pleural
effusions,4e8 we compared these markers in one cohort and
explored the diagnostic capacities. Local levels of sTREM-1
and CRP were elevated both in patients with empyemas or
exudates. Local PCT levels were only found to be elevated
in patients with infectious exudates. Moreover, sTREM-1
was demonstrated to be superior to CRP and PCT to detect
local infection.
Several limitations of our study have to be acknowl-
edged. First, we included a limited number of patients.
While the present study was designed to explore the
differences between sTREM-1, CRP and PCT we may not
have included a sufficient number of patients to calculate
sensitivities and specificities that can be generalized to all
intensive care patients. Second, in fact we only included
intensive care patients with an acute presentation ofsTREM-1
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Figure 3 Receiver operating characteristic curves of levels of solu
C-reactive protein and procalcitonin in patients with pleural eff
pleural effusions.pleural effusion, but our main goal was to explore whether
the studied markers can be used to diagnose acute infec-
tion in this setting. Therefore, our results cannot be
extended to other patient groups. Third, we did not
measure the parameters in plasma samples. This may be
considered an important drawback because plasma levels
might reveal infection without the need to aspire fluid.
However, increased plasma sTREM-1 levels are not specific
for any kind of infection and aspiration of fluid may still be
needed to rule out infection in the pleural cavity.
Previous studies have shown that CRP can adequately
differentiate transudates from exudates in case of pleural
effusion.9,10 Sensitivities of 74%e94% and specificities of 74%e
76% have been reported. However, reports on the capacity of
CRP to distinguish infectious from non-infectious effusions
have not been performed before. However, a recent study
suggested that CRP levels in pleural effusionsmight be used to
differentiate between categories of severity of infection.8 In
that study, patients with complicated parapneumonic effu-
sions or empyema had higher local CRP levels as compared to
patients with uncomplicated parapneumonic effusions. In our
study, patients with empyema indeed had the highest CRP
levels, followed by patients with infectious exudates. Our
study was not powered to show differences between these
subgroups but CRP levels were significantly lower in non-
infectious effusions. Some patients with exudative fluid
showedhighCRP levels.Thismayhavebeencausedby the fact
that we studied intensive care patients, whereas all previousRP
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sTREM-1 levels in pleural effusions 315studies on CRP levels in pleural effusions were performed in
non-critically ill patients. Intensive care patients may have
higher baseline levels of systemic inflammation as compared
to the other patients. As CRP is a non-specific marker of
inflammation, higher levels in pleural fluid may simply reflect
higher systemic levels.
We observed that sTREM-1 was superior to CRP and
PCT in differentiating between infected and non-infected
pleural effusions. This confirms findings of previous
studies on sTREM-1 in pleural effusions, 4,5 and shows
that sTREM-1 may be the candidate marker as a diag-
nostic tool to detect infection. While current chemistry
analyses provide information on presence of exudates or
transudates, sTREM-1 could be the biological marker that
detects infection before bacteriological studies are per-
formed. Future studies may compare Gram-staining with
sTREM-1 measurement as a rapid method for detection of
infection.
In conclusion, based on the present study, sTREM-1
appears a highly useful marker to differentiate between
infectious and non-infectious pleural effusions. Moreover,
sTREM-1 appears superior to CRP and PCT for this
purpose. Awaiting bacteriological culture results, sTREM-1
may aid in early detection of infection and guide early
treatment.
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